Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers

NCT05255016 is registered in ClinicalTrials.gov with Peschke GmbH as lead sponsor.

NCT NCT05255016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05255016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
Lead sponsor
Peschke GmbH
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 14, 2022
Completion date
February 24, 2024
Enrollment
488 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ulcer, keratitis